About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials in Atlanta | 175 Studies

Clinical Trials Colorectal CancerAtlanta

Colorectal Cancer Clinical Trials in Atlanta

Find 175 clinical trials for colorectal cancer near Atlanta, Georgia. Connect with research centers in your area.

All Colorectal Cancer trials nationwide All trials in Atlanta

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 175 trials

RecruitingAMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid TumorsThe purpose of this first-in-human study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of AMG 410 when…NCT07094113·Duarte, California and 38 others

Colorectal Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedStudy of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal CancerA Phase 1/1b dose finding study to determine the OBD(s) and RP2D(s) of BMF-219, a covalent menin inhibitor small molecule, in subjects with KRAS mutated unresectable, locally…NCT05631574·Goodyear, Arizona and 22 others

CompletedLaparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon CancerRATIONALE: Less invasive types of surgery may help reduce the number of side effects and improve recovery.NCT00002575·Huntsville, Alabama and 157 others

CompletedPhase 1 and 2 Study of PX-866 and CetuximabThe purpose of this Phase 1/2 open-label study is to determine the safety and efficacy of a cetuximab and PX-866 combination treatment.NCT01252628·Birmingham, Alabama and 39 others

CompletedVitamin D/Calcium Polyp Prevention StudyExtensive experimental and observational data suggest that intake of calcium and of vitamin D exert protective effects on colorectal neoplasia.NCT00153816·Los Angeles, California and 10 others

CompletedHead to Head Study Epi proColon and FITThe study aims to show non-inferiority in the clinical performance of the investigational assay, Epi proColon, to FIT using matched blood and stool specimens from…NCT01580540·Birmingham, Alabama and 69 others

Active not recruitingStudy of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsThis is a multicenter Phase 1b, open-label study to assess safety, tolerability, preliminary efficacy, and pharmacokinetics (PK) of cabozantinib taken in combination with…NCT03170960·Gilbert, Arizona and 123 others

CompletedCapecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal CancerThis randomized phase II trial studies how well capecitabine and bevacizumab with or without atezolizumab work in treating patients with colorectal cancer that is not responding…NCT02873195·Phoenix, Arizona and 9 others

CompletedVX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal CancerThis randomized phase I trial studies how well anti-semaphorin 4D (anti-SEMA4D) monoclonal antibody VX15/2503 with or without ipilimumab or nivolumab work in treating patients…NCT03373188·Atlanta, Georgia and 3 others

UnknownPanitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal CancerThis phase II trial studies how well retreatment with panitumumab works compared to standard of care regorafenib or trifluridine and tipiracil hydrochloride (TAS-102) in treating…NCT03992456·Scottsdale, Arizona and 17 others

CompletedBinimetinib and Palbociclib or TAS-102 in Treating Patients With KRAS and NRAS Mutant Metastatic or Unresectable Colorectal CancerThis phase II trial studies how well binimetinib and palbociclib work compared to TAS-102 in treating patients with KRAS and NRAS mutation positive colorectal cancer that has…NCT03981614·Scottsdale, Arizona and 6 others

CompletedBevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard ChemotherapyRATIONALE: Bevacizumab may stop the growth of tumor cells by blocking the enzymes necessary for cancer cell growth.NCT00066846·Anchorage, Alaska and 32 others

TerminatedA Study of BDTX-189, an Orally Available Allosteric ErbB Inhibitor, in Patients With Advanced Solid Tumors.This was a clinical study with an orally administered drug, BDTX-189 in participants with advanced solid tumors that had select mutations or alterations in human epidermal growth…NCT04209465·Scottsdale, Arizona and 37 others

Active not recruitingNational Cancer Institute "Cancer Moonshot Biobank"This trial collects multiple tissue and blood samples, along with medical information, from cancer patients. The "Cancer Moonshot Biobank" is a longitudinal study.NCT04314401·Daphne, Alabama and 149 others

CompletedMulti-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development StudiesThe objective of this study is to confirm the sensitivity of a stool DNA test for detection of colorectal cancer and pre-cancer.NCT01260168·Birmingham, Alabama and 20 others

TerminatedA Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal CancerThe purpose of this study is to evaluate relatlimab in combination with nivolumab, administered as a fixed-dose combination (nivolumab-relatlimab FDC, also referred to as…NCT05328908·Springdale, Arkansas and 138 others

CompletedS0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically RemovedRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00049335·Mobile, Alabama and 89 others

CompletedCHOICE: Communicating Health Options Through Information and Cancer EducationThe purpose of this study is to determine the effectiveness of a two-component intervention, that combines academic detailing at the medical practice level and distribution of…NCT00134589·Atlanta, Georgia

TerminatedEfficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal AdenocarcinomaThe primary objective of this study is to compare the additive efficacy of SIM versus placebo in combination with leucovorin (folinic acid), irinotecan, and fluorouracil (FOLFIRI)…NCT01479465·Huntsville, Alabama and 108 others

CompletedPhase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid TumorsThe purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of intravenous (IV) administration of XmAb808 in combination with pembrolizumab in subjects…NCT05585034·Los Angeles, California and 11 others

PreviousPage 5 of 9Next

Other Conditions in Atlanta

Breast Cancer Lung Cancer Prostate Cancer Melanoma Leukemia Lymphoma